GlassScriptPhysician profile
Theodore D Richards
NPI 1891784518
$4,139.54
in general payments reported to CMS, 2019-2025
31 companies · $32.74 in 2025
The $32.74 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $502 · 2021: $1,223 · 2022: $930 · 2023: $454 · 2024: $346 · 2025: $32.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $616.05 | 2019-2022 | |
| Boston Scientific Corporation | $492.78 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, Watchman Flx |
| Janssen Pharmaceuticals, INC | $365.17 | 2019-2022 | |
| Abbott Laboratories | $362.09 | 2020-2024 | Aptivue, Aveir, Perclose Prostyle |
| Astellas Pharma US INC | $234.67 | 2019-2021 | |
| Shockwave Medical, INC | $186.67 | 2022 | |
| Abiomed | $174.08 | 2021-2024 | Impella |
| Penumbra, INC. | $167.96 | 2023 | Indigo System |
| Amgen INC. | $156.27 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.27 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.89 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $128.66 | 2023-2024 | Definity |
| Merck Sharp & Dohme LLC | $125.12 | 2021-2022 | |
| Pfizer INC. | $117.33 | 2019-2023 | |
| Celonova Biosciences, INC. | $103.04 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $88.49 | 2021-2022 | |
| Amarin Pharma, INC. | $87.63 | 2019-2021 | |
| Lundbeck LLC | $80.81 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $63.40 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $61.59 | 2019-2021 | |
| Ge Healthcare | $56.37 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $43.81 | 2019 | |
| Medtronic, INC. | $33.26 | 2021 | |
| Acist Medical Systems, INC. | $25.18 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $23.87 | 2019-2021 | |
| Stryker Corporation | $18.14 | 2025 | Flowtriever |
| Scpharmaceuticals INC. | $17.30 | 2023 | |
| Terumo Medical Corporation | $15.17 | 2023 | Angio-Seal |
| Edwards Lifesciences Corporation | $12.17 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.40 | 2019 | |
| Elutia, INC. | $8.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.